| Features: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Organic compound isolated from rhubarb, buckthorn, knotweed. It has laxative, anticancer, antibacterial, antiinflammatory, and antiviral activities, and is used in traditional Chinese medicine. Emodin, an anthraquinone derivative found in various plants (e.g., rhubarb, Polygonum cuspidatum). Pathways: - Generation of Reactive Oxygen Species (ROS) - Upregulation Bax downregulation of Bcl‑2, caspase activation and cyt_c release. - Induce cell cycle arrest at various checkpoints (commonly G0/G1 or G2/M phases. - Can inhibit NF‑κB activation – MAPK Pathways – PI3K/Akt Pathway - Metalloproteinases (MMPs) -ic50 cancer cells 10-50uM, normal cells higher(supports a therapeutic window)
|
| Source: |
| Type: |
| Thymidylate synthase (TS) is a key enzyme responsible for catalyzing the methylation of deoxyuridine monophosphate (dUMP) to deoxythymidine monophosphate (dTMP), a crucial step in the synthesis of thymidine—one of the four nucleotides required for DNA replication and repair. Due to its essential role in DNA synthesis, TS is a critical target for chemotherapeutic agents such as 5-fluorouracil (5-FU) and other antifolates. Many cancers exhibit elevated levels of TS expression compared to normal tissues. High TS expression can contribute to rapid cell proliferation and tumor growth by ensuring a sufficient supply of thymidine for DNA synthesis. Thymidylate synthase (TS) plays a central role in DNA synthesis and cell proliferation, making it a critical enzyme in cancer biology. Overexpression of TS is commonly observed in a range of tumor types and is associated with increased cellular proliferation, drug resistance, and generally poorer clinical outcomes. As both a therapeutic target and a prognostic marker, TS levels offer insight into tumor aggressiveness and potential responsiveness to chemotherapeutic agents. |
| 1329- | EMD, | Aloe-emodin induces cell death through S-phase arrest and caspase-dependent pathways in human tongue squamous cancer SCC-4 cells |
| - | in-vitro, | Tong, | SCC4 |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:75 Target#:1064 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid